Civic Intelligence

T a G Treatment Action Group Inc.

990 • Fiscal year 2019 • EIN 13-3624785

Jan 01, 2019 to Dec 31, 2019 • Filed on Aug 26, 2020

90 Broad Street No 2503New York, NY 10004

(212) 253-7922

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

36th percentile

0.03x

Higher debt load relative to assets than 36% of similar nonprofits.

2019 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2019

Liabilities / Revenue

33rd percentile

0.03x

Higher debt load relative to revenue than 33% of similar nonprofits.

2019 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2019

Net Margin

11th percentile

-27%

Higher net margin than 11% of similar nonprofits.

2019 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2019

Top Officer Pay

87th percentile

$175,972

Higher top officer pay than 87% of similar nonprofits.

Top officer pay equals 8.1% of source-year revenue.

2019 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2019

Asset Growth

7th percentile

-18%

Faster asset growth than 7% of similar nonprofits.

2019 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2018 to 2019

Revenue Growth

75th percentile

20%

Faster revenue growth than 75% of similar nonprofits.

2019 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2018 to 2019

Assets

Down

$2,736,460

Down $586,305 (-18%) from 2018

Net Assets

Down

$2,664,495

Down $590,354 (-18%) from 2018

Liabilities

Up

$71,965

Up $4,049 (+6.0%) from 2018

Revenue

Up

$2,174,190

Up $364,976 (+20%) from 2018

Expenses

Up

$2,764,544

Up $253,581 (+10%) from 2018

Net Income

Up

-$590,354

Up $111,395 (+16%) from 2018

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$6.0M$4.0M$2.0M$0Assets 2010: $2,248,827Liabilities 2010: $2,860Net Assets 2010: $2,245,9672010Assets 2011: $2,679,042Liabilities 2011: $23,023Net Assets 2011: $2,656,0192011Assets 2012: $2,851,951Liabilities 2012: $25,636Net Assets 2012: $2,826,3152012Assets 2013: $1,880,235Liabilities 2013: $41,213Net Assets 2013: $1,839,0222013Assets 2014: $3,811,240Liabilities 2014: $30,523Net Assets 2014: $3,780,7172014Assets 2015: $3,609,971Liabilities 2015: $20,734Net Assets 2015: $3,589,2372015Assets 2016: $2,592,218Liabilities 2016: $74,083Net Assets 2016: $2,518,1352016Assets 2017: $2,575,844Liabilities 2017: $80,729Net Assets 2017: $2,495,1152017Assets 2018: $3,322,765Liabilities 2018: $67,916Net Assets 2018: $3,254,8492018Assets 2019: $2,736,460Liabilities 2019: $71,965Net Assets 2019: $2,664,4952019Assets 2020: $4,649,413Liabilities 2020: $282,097Net Assets 2020: $4,367,3162020Assets 2021: $3,776,196Liabilities 2021: $356,091Net Assets 2021: $3,420,1052021Assets 2022: $3,549,278Liabilities 2022: $931,291Net Assets 2022: $2,617,9872022Assets 2023: $4,624,032Liabilities 2023: $1,012,949Net Assets 2023: $3,611,0832023Assets 2024: $3,839,139Liabilities 2024: $745,777Net Assets 2024: $3,093,3622024

Highlighted filing

2019

Assets$2,736,460
Liabilities$71,965
Net Assets$2,664,495

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2010: $1,912,416Expenses 2010: $2,198,624Net Income 2010: -$286,2082010Revenue 2011: $1,886,646Expenses 2011: $1,677,094Net Income 2011: $209,5522011Revenue 2012: $2,042,960Expenses 2012: $1,872,664Net Income 2012: $170,2962012Revenue 2013: $1,458,571Expenses 2013: $2,437,127Net Income 2013: -$978,5562013Revenue 2014: $4,424,915Expenses 2014: $2,483,220Net Income 2014: $1,941,6952014Revenue 2015: $2,230,880Expenses 2015: $2,419,194Net Income 2015: -$188,3142015Revenue 2016: $1,623,672Expenses 2016: $2,690,029Net Income 2016: -$1,066,3572016Revenue 2017: $2,619,130Expenses 2017: $2,642,336Net Income 2017: -$23,2062017Revenue 2018: $1,809,214Expenses 2018: $2,510,963Net Income 2018: -$701,7492018Revenue 2019: $2,174,190Expenses 2019: $2,764,544Net Income 2019: -$590,3542019Revenue 2020: $4,690,654Expenses 2020: $2,987,833Net Income 2020: $1,702,8212020Revenue 2021: $2,714,054Expenses 2021: $3,661,265Net Income 2021: -$947,2112021Revenue 2022: $2,911,955Expenses 2022: $3,714,073Net Income 2022: -$802,1182022Revenue 2023: $4,736,176Expenses 2023: $3,743,080Net Income 2023: $993,0962023Revenue 2024: $3,574,921Expenses 2024: $4,092,642Net Income 2024: -$517,7212024

Highlighted filing

2019

Revenue$2,174,190
Expenses$2,764,544
Net Income-$590,354
Jump To
Filing Snapshot
Filing Period
Jan 1, 2019 to Dec 31, 2019
Signed
Aug 26, 2020
Return Version
2019v5.1
Gross Receipts
$2,295,112
Mission and Program Overview

Mission

Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. Tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.

T.a.g. Treatment action group, inc. ("tag") is a not-for-profit organization incorporated under the laws of the state of new york. Founded in january 1992, tag is an independent, activist, and community-based research and policy think tank fighting for better treatment, prevention, a vaccine, and a cure for hiv, tuberculosis (tb), and hepatitis c virus (hcv). Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. Tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.the primary sources of revenue to tag are contributions and grants.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$1,524,329$1,584,874▲ $60,545
Pledges and Grants Receivable$1,216,871$496,981▼ $719,890
Prepaid Expenses and Deferred Charges$31,594$37,208▲ $5,614
Cash and Non-Interest-Bearing Accounts$9,902$26,032▲ $16,130
Land, Buildings, and Equipment, Net$26,728$18,580▼ $8,148
Accounts Receivable$1,139$7,583▲ $6,444
Total Assets$3,322,765$2,736,460▼ $586,305
Other Assets Total$512,202$565,202▲ $53,000
Liabilities
Accounts Payable and Accrued Expenses$25,396$38,603▲ $13,207
Other Liabilities$42,520$33,362▼ $9,158
Total Liabilities$67,916$71,965▲ $4,049
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$1,736,034$1,537,543▼ $198,491
Net Assets With Donor Restrictions$1,518,815$1,126,952▼ $391,863
Total Net Assets Fund Balance$3,254,849$2,664,495▼ $590,354
Total Liabilities and Net Assets / Fund Balance$3,322,765$2,736,460▼ $586,305

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$18,580$65,555$84,135
Other Assets Org$492,739--
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Mark HarringtonExecutive DirectorFT$160,894$15,078$175,972
Erica M LessemDeputy Executive DirectorFT$133,612$15,078$148,690

Board Members and Trustees

NameTitle
Barbara HughesPresident
Bobby MclainVice President
David I SigalDirector
Dick DadeyDirector
Eddie PeltoDirector
Frank BuaDirector
Jameel JiwaniDirector
Jim AquinoDirector
Joy EpisallaDirector
Kevin GoetzDirector
Mrinal VikramDirector
Nick DebsDirector
Richard Lynn PhdDirector
Robert MonteleoneDirector
Roy M Gulick Md MphDirector
Jeff MendozaDirector (through 12/19)
Monte SteinmanDirector (through 12/19)
Robert W LennonSecretary
Laura MorrisonTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$2,144,930
Program Service Revenue
$27,413
Investment Income
$1,347
Other Revenue
$500
All Other Contributions
$1,835,521
Change in Net Assets
$-590,354

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
No
Third parties used for noncash contributions
No

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Works of Art1$150,000Selling Value
Other Non Cash Contri Table2$19,925Fair Market Value
Total Noncash Contributions3$169,925-

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,174,190
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$2,174,190
Total Revenue per Form 990
$2,174,190
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$1,641,139
Other Expenses$987,420
Total Fundraising Expense$240,152
Grants and Similar Amounts Paid$135,985
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$853,802$190,445$63,171$1,107,418
Other Employee Benefits$197,612$45,967$20,402$263,981
Fees for Services Other$243,111$18,288$437$261,836
Travel$251,761$447$1,704$253,912
Occupancy$134,949$35,319$17,161$187,429
Current Officers, Directors, Trustees, and Key Employees$84,466$35,194$56,312$175,972
Payroll Taxes$68,832$16,459$8,477$93,768
Grants to Domestic Orgs$88,450--$88,450
Office Expenses$37,009$6,870$22,137$66,016
Foreign Grants$47,535--$47,535
Conferences and Meetings$31,224--$31,224
Fees for Services Accounting-$20,673-$20,673
Insurance$13,264$3,471$1,687$18,422
Information Technology$8,563$1,104$951$10,618
Depreciation Depletion$6,875$1,798$874$9,547
Fees for Services Legal$476$2,115-$2,591
Other Expenses$529$971$30$1,530
Advertising$443$129$478$1,050
Total Functional Expenses$2,144,669$379,723$240,152$2,764,544

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$2,764,544
Total Expenses per Audited Statements$2,764,544
Total Expenses per Form 990$2,764,544
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Prep4allBrooklyn, NY-Fiscal Sponsorship$73,450
Act UpNew York, NY-Fiscal Sponsorship$15,000

International Summary

Offices
0
Employees
0
Spending
$257,674

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
East Asia and the PacificProgram ServicesTb Prevention & Advocacy Workshop00$78,794
Middle East and North AfricaProgram ServicesTb Advocacy- Marrakech00$38,292
Sub-saharan AfricaGrantsTb Advocacy - South Africa00$37,535
East Asia and the PacificProgram ServicesHcv Advocacy & Dx Workshop00$22,641
South AsiaProgram ServicesTb Iuatld Conference- India00$19,506
Russia and Neighboring StatesProgram ServicesHcv Harm Reduction- Georgia00$17,064
Central America and the CaribbeanProgram ServicesHiv Ias Conference - Mexico00$12,801
North AmericaProgram ServicesInhsu Conference- Canada00$7,697
Europe (including Iceland and Greenland)Program ServicesTb Advocacy - Geneva00$5,471
East Asia and the PacificGrantsTb Advocacy00$5,000
South AmericaGrantsTb Advocacy - Brazil00$5,000
Sub-saharan AfricaProgram ServicesTb Advocacy - South Africa00$4,500
Europe (including Iceland and Greenland)Program ServicesHcv Harm Reductio- Portugal00$1,726
Sub-saharan AfricaProgram ServicesInhsu Conference- South Africa00$1,647
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$79,422
Fundraising Gross Income$79,422
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Riaa$287,848$79,422$16,580$62,842
Total Events$287,848$79,422$79,422$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent Liability$33,362
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

A draft of form 990 was sent to members of the board of directors for review and approval. The audit committee reviewed the form 990 and reported to the executive committee and the board of directors before the return was filed with the irs.

Form 990, Part VI, Section B, Line 12C

Conflict of interest policy requires board members and key staff to complete an annual disclosure statement. The related individual will be excluded from the discussion and the voting process.

Form 990, Part VI, Section B, Line 15

Compensation for key employees is reviewed and approved by the executive director. Compensation for executive director is reviewed and approved by the board of directors.

Form 990, Part VI, Section C, Line 19

The organization's governing documents are available upon request. Annual reports are available on the organization's website.

Filing and Contact Details

Filer

Filer Name
Tag Treatment Action Group Inc
EIN
13-3624785
Phone
2122537922
Address
90 BROAD STREET NO 2503, NEW YORK, NY 10004

Signing Officer

Name
Laura Morrison
Title
Secretary/treasurer
Phone
2122537922
Signed
2020-08-26
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Laura Morrison
Formed
1992
Legal Domicile
Ny
Voting Board Members
19
Independent Board Members
18
Employees
17
Volunteers
30

Preparer

Firm
Lutz and Carr Cpas Llp
Address
551 FIFTH AVE SUITE 400, NEW YORK, NY 10176
Preparer
Michael Wallace
Phone
2126972299
Supplemental Narrative

Financial Statement Notes

PART III, LINE 4:

The art prints are sold as part of the ticket package for major donors of the research in action awards event and subsequently sold as individual editions.

Raw XML AppendixShowing 400 of 781 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt025396
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt038603
IRS990/AccountsReceivableGrp/BOYAmt01139
IRS990/AccountsReceivableGrp/EOYAmt07583
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0T.A.G. TREATMENT ACTION GROUP, INC. ("TAG") IS A NOT-FOR-PROFIT ORGANIZATION INCORPORATED UNDER THE LAWS OF THE STATE OF NEW YORK. FOUNDED IN JANUARY 1992, TAG IS AN INDEPENDENT, ACTIVIST, AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK FIGHTING FOR BETTER TREATMENT, PREVENTION, A VACCINE, AND A CURE FOR HIV, TUBERCULOSIS (TB), AND HEPATITIS C VIRUS (HCV). TAG WORKS TO ENSURE THAT ALL PEOPLE WITH HIV, TB, OR HCV RECEIVE LIFESAVING TREATMENT, CARE, AND INFORMATION. TAG IS SCIENCE-BASED TREATMENT ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS. TAG CATALYZES OPEN COLLECTIVE ACTION BY ALL AFFECTED COMMUNITIES, SCIENTISTS, AND POLICY MAKERS TO END HIV, TB, AND HCV.THE PRIMARY SOURCES OF REVENUE TO TAG ARE CONTRIBUTIONS AND GRANTS.
IRS990/AdvertisingGrp/FundraisingAmt0478
IRS990/AdvertisingGrp/ManagementAndGeneralAmt0129
IRS990/AdvertisingGrp/ProgramServicesAmt0443
IRS990/AdvertisingGrp/TotalAmt01050
IRS990/AllOtherContributionsAmt01835521
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0SABRINA GUERRERO-MORRIS
IRS990/BooksInCareOfDetail/PhoneNum02122537922
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt090 BROAD STREET NO 2503
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd010004
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt09902
IRS990/CashNonInterestBearingGrp/EOYAmt026032
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd01
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt056312
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt035194
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt084466
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0175972
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt031224
IRS990/ConferencesMeetingsGrp/TotalAmt031224
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0208426
IRS990/CostOfGoodsSoldAmt041500
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt02144930
IRS990/CYGrantsAndSimilarPaidAmt0135985
IRS990/CYInvestmentIncomeAmt01347
IRS990/CYOtherExpensesAmt0987420
IRS990/CYOtherRevenueAmt0500
IRS990/CYProgramServiceRevenueAmt027413
IRS990/CYRevenuesLessExpensesAmt0-590354
IRS990/CYSalariesCompEmpBnftPaidAmt01641139
IRS990/CYTotalExpensesAmt02764544
IRS990/CYTotalFundraisingExpenseAmt0240152
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02174190
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd01
IRS990/DeductibleNonCashContriInd01
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt0874
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt01798
IRS990/DepreciationDepletionGrp/ProgramServicesAmt06875
IRS990/DepreciationDepletionGrp/TotalAmt09547
IRS990/Desc0SEE SCHEDULE OHIVTAG'S HIV PROJECT WORKS TO MAXIMIZE EQUITABLE, AFFORDABLE ACCESS TO THE TOOLS, SERVICES, POLICIES, AND APPROACHES TO CARE THAT WE KNOW CAN END HIV. ENDING THE EPIDEMIC (ETE) ADVOCACY IS AT THE CORE OF THE HIV PROJECT'S WORK, FROM DRIVING THE NATION'S FIRST ETE INITIATIVE IN NEW YORK TO LEADING THE ACT NOW: END AIDS COALITION'S SUPPORT FOR PARTNERS IN HEAVILY BURDENED JURISDICTIONS IN THE SOUTHERN U.S. TAG'S HIV AND POLICY TEAMS TACKLE ISSUES AROUND DRUG PRICING, FUNDING FOR EVIDENCE-BASED HIV PROGRAMMING, ACCESS TO HEALTHCARE, AND POLICIES THAT PROMOTE SAFE, INCLUSIVE ENVIRONMENTS FREE OF STIGMA AND DISCRIMINATION FOR PEOPLE TO SEEK PREVENTION AND CARE FOR HIV AND RELATED INFECTIONS, INCLUDING SEXUALLY TRANSMITTED INFECTIONS.TAG'S HIV PROJECT LEADS RESEARCH ACTIVISM AND PROMOTES COMMUNITY ENGAGEMENT TO ENSURE THAT PEOPLE LIVING WITH HIV EVERYWHERE HAVE MORE OPTIONS INCLUDING, ULTIMATELY, A SAFE AND EFFECTIVE HIV VACCINE AND A CURE THAT'S SCALABLE, AFFORDABLE, AND CAN BE USED WORLDWIDE. TAG'S HIV PROJECT RECOGNIZES THAT EVEN THE MOST EFFECTIVE EXISTING PREVENTION AND TREATMENT INTERVENTIONS HAVE SHORTCOMINGS. TO THIS END, TAG TRACKS THE ANTIRETROVIRAL, CURE, IMMUNE-BASED THERAPY, AND PREVENTION PIPELINES, AND PLAYS A VITAL LEADERSHIP ROLE IN BASIC SCIENCE, VACCINES, AND CURE ADVOCACY. OUR HIV CURE-RELATED CLINICAL TRIALS WEBSITE LISTING, UPDATED MONTHLY TO PROVIDE INFORMATION ON STUDIES AND THEIR RESULTS, IS WIDELY CITED BY RESEARCHERS AND PARTNERS IN SCIENTIFIC PAPERS AND IN CONFERENCE PRESENTATIONS. THE HIV PROJECT ALSO ADVOCATES FOR APPROPRIATE INTERVENTIONS FOR PEOPLE WHO, DESPITE HIV TREATMENT, STILL HAVE POOR IMMUNE SYSTEM RECOVERY. CENTRAL TO THIS WORK IS ENSURING LEGISLATORS AND POLICY MAKERS UNDERSTAND THE NEED FOR RESEARCH FUNDING, AND HOW IMPORTANT IT IS TO MAKE DECISIONS BASED ON SCIENTIFIC EVIDENCE.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt01518815
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt01126952
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt017
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0590447
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt020673
IRS990/FeesForServicesAccountingGrp/TotalAmt020673
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt02115
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0476
IRS990/FeesForServicesLegalGrp/TotalAmt02591
IRS990/FeesForServicesOtherGrp/FundraisingAmt0437
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt018288
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0243111
IRS990/FeesForServicesOtherGrp/TotalAmt0261836
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt047535
IRS990/ForeignGrantsGrp/TotalAmt047535
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt09.60
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt10.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt22.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt100.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt110.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt120.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt130.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt141.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt151.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt160.40
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt171.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt180.70
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2040.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd13X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd14X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd15X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd16X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd17X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd18X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt130
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt140
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt150
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt160
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt170
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt180
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1915078
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2015078
IRS990/Form990PartVIISectionAGrp/PersonNm0BARBARA HUGHES
IRS990/Form990PartVIISectionAGrp/PersonNm1BOBBY MCLAIN
IRS990/Form990PartVIISectionAGrp/PersonNm2LAURA MORRISON
IRS990/Form990PartVIISectionAGrp/PersonNm3ROBERT W LENNON
IRS990/Form990PartVIISectionAGrp/PersonNm4JIM AQUINO
IRS990/Form990PartVIISectionAGrp/PersonNm5FRANK BUA
IRS990/Form990PartVIISectionAGrp/PersonNm6DICK DADEY
IRS990/Form990PartVIISectionAGrp/PersonNm7NICK DEBS
IRS990/Form990PartVIISectionAGrp/PersonNm8JOY EPISALLA
IRS990/Form990PartVIISectionAGrp/PersonNm9KEVIN GOETZ
IRS990/Form990PartVIISectionAGrp/PersonNm10ROY M GULICK MD MPH
IRS990/Form990PartVIISectionAGrp/PersonNm11JAMEEL JIWANI
IRS990/Form990PartVIISectionAGrp/PersonNm12RICHARD LYNN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm13JEFF MENDOZA
IRS990/Form990PartVIISectionAGrp/PersonNm14ROBERT MONTELEONE
IRS990/Form990PartVIISectionAGrp/PersonNm15EDDIE PELTO
IRS990/Form990PartVIISectionAGrp/PersonNm16DAVID I SIGAL
IRS990/Form990PartVIISectionAGrp/PersonNm17MONTE STEINMAN
IRS990/Form990PartVIISectionAGrp/PersonNm18MRINAL VIKRAM
IRS990/Form990PartVIISectionAGrp/PersonNm19MARK HARRINGTON
IRS990/Form990PartVIISectionAGrp/PersonNm20ERICA M LESSEM
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt19160894
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20133612
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt190
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt200
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt13DIRECTOR (THROUGH 12/19)
IRS990/Form990PartVIISectionAGrp/TitleTxt14DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt15DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt16DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt17DIRECTOR (THROUGH 12/19)
IRS990/Form990PartVIISectionAGrp/TitleTxt18DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt19EXECUTIVE DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt20DEPUTY EXECUTIVE DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr01992
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0208426
IRS990/FundraisingDirectExpensesAmt079422
IRS990/FundraisingGrossIncomeAmt079422
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt019
IRS990/GovernmentGrantsAmt0100983
IRS990/GrantAmt088450
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt088450
IRS990/GrantsToDomesticOrgsGrp/TotalAmt088450
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt02295112
IRS990/GrossSalesOfInventoryAmt042000
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt018
IRS990/IndivRcvdGreaterThan100KCnt02
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt0951
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt01104
IRS990/InformationTechnologyGrp/ProgramServicesAmt08563
IRS990/InformationTechnologyGrp/TotalAmt010618
IRS990/InsuranceGrp/FundraisingAmt01687
IRS990/InsuranceGrp/ManagementAndGeneralAmt03471
IRS990/InsuranceGrp/ProgramServicesAmt013264
IRS990/InsuranceGrp/TotalAmt018422
IRS990/InvestmentIncomeGrp/ExclusionAmt01347
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt01347
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt015
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt065555
IRS990/LandBldgEquipBasisNetGrp/BOYAmt026728
IRS990/LandBldgEquipBasisNetGrp/EOYAmt018580
IRS990/LandBldgEquipCostOrOtherBssAmt084135
IRS990/LegalDomicileStateCd0NY
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TAG WORKS TO ENSURE THAT ALL PEOPLE WITH HIV, TB, OR HCV RECEIVE LIFESAVING TREATMENT, CARE, AND INFORMATION. TAG IS SCIENCE-BASED TREATMENT ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS. TAG CATALYZES OPEN COLLECTIVE ACTION BY ALL AFFECTED COMMUNITIES, SCIENTISTS, AND POLICY MAKERS TO END HIV, TB, AND HCV.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt03254849
IRS990/NetAssetsOrFundBalancesEOYAmt02664495
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/ExclusionAmt0500
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt0500
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt01736034
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt01537543
IRS990/NoncashContributionsAmt0169925
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt017161
IRS990/OccupancyGrp/ManagementAndGeneralAmt035319
IRS990/OccupancyGrp/ProgramServicesAmt0134949
IRS990/OccupancyGrp/TotalAmt0187429
IRS990/OfficeExpensesGrp/FundraisingAmt022137
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt06870
IRS990/OfficeExpensesGrp/ProgramServicesAmt037009
IRS990/OfficeExpensesGrp/TotalAmt066016
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0512202
IRS990/OtherAssetsTotalGrp/EOYAmt0565202
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt020402
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt045967
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0197612
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0263981
IRS990/OtherExpensesGrp/Desc0PRINTING & PUBLICATIONS
IRS990/OtherExpensesGrp/Desc1FUNDRAISING EVENTS
IRS990/OtherExpensesGrp/Desc2DUES AND SUBSCRIPTIONS
IRS990/OtherExpensesGrp/Desc3MISCELLANEOUS
IRS990/OtherExpensesGrp/FundraisingAmt011201
IRS990/OtherExpensesGrp/FundraisingAmt135130
IRS990/OtherExpensesGrp/FundraisingAmt230
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0473
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt1971
IRS990/OtherExpensesGrp/ProgramServicesAmt056780
IRS990/OtherExpensesGrp/ProgramServicesAmt118988
IRS990/OtherExpensesGrp/ProgramServicesAmt2529
IRS990/OtherExpensesGrp/TotalAmt068454
IRS990/OtherExpensesGrp/TotalAmt135130
IRS990/OtherExpensesGrp/TotalAmt218988
IRS990/OtherExpensesGrp/TotalAmt31530
IRS990/OtherLiabilitiesGrp/BOYAmt042520
IRS990/OtherLiabilitiesGrp/EOYAmt033362
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt063171
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0190445
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0853802
IRS990/OtherSalariesAndWagesGrp/TotalAmt01107418
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt08477
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt016459
IRS990/PayrollTaxesGrp/ProgramServicesAmt068832
IRS990/PayrollTaxesGrp/TotalAmt093768
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt01216871
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0496981
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt031594
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt037208
IRS990/PrincipalOfficerNm0LAURA MORRISON
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0900099
IRS990/ProgramServiceRevenueGrp/Desc0OTHER PROGRAM INCOME
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt027413
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt027413
IRS990/ProgSrvcAccomActy2Grp/Desc0SEE SCHEDULE OHCVGLOBALLY, OVER 71 MILLION PEOPLE ARE ESTIMATED TO HAVE HEPATITIS C VIRUS (HCV). DESPITE THE AVAILABILITY OF ALL-ORAL, SHORT-COURSE DIRECT-ACTING ANTIVIRALS (DAAS) THAT TREAT ALL HCV GENOTYPES, AND NEARLY HALF A MILLION PEOPLE DIE FROM THIS PREVENTABLE, CURABLE INFECTION.THE HCV PROJECT HAS BEEN AT THE FOREFRONT OF A GLOBAL HCV EDUCATION AND ADVOCACY MOVEMENT, WORKING IN COLLABORATION WITH AFFECTED COMMUNITIES, SCIENTISTS, GOVERNMENT, AND DRUG COMPANIES TO MAKE LIFE-SAVING INFORMATION, HIGH QUALITY AND AFFORDABLE TESTING AND CURES, AND SUPPORTIVE ENVIRONMENTS FOR UNDERSERVED POPULATIONS UNIVERSALLY AVAILABLE. THIS INCLUDES TRACKING THE PIPELINE FOR HCV INNOVATIONS, INCLUDING THE LATEST PANGENOTYPIC TREATMENTS, DIAGNOSTICS, AND LONG-ACTING INJECTABLES, AND INCREASING COMMUNITIES' DIAGNOSTICS AND TREATMENT LITERACY. GLOBALLY, TAG PROVIDES TECHNICAL ASSISTANCE TO BUILD LEADERSHIP CAPACITY FOR ADVANCING NATIONAL ELIMINATION CAMPAIGNS AND AMPLIFYING COMMUNITY VOICES-ESPECIALLY THOSE OF KEY POPULATIONS SUCH AS PEOPLE WHO USE DRUGS, SEX WORKERS, PRISONERS, MIGRANTS, AND MEN WHO HAVE SEX WITH MEN-IN PLANNING AND POLICY DEVELOPMENT.TAG'S HCV PROJECT AIMS TO OVERCOME BARRIERS TO ACCESS-FROM LIMITED DONOR FUNDING FOR HCV, TO SOBRIETY AND ADHERENCE RESTRICTIONS IMPOSED BY GOVERNMENTS AND PAYERS, TO PATENT AND PRICING BARRIERS, TO LIMITED VOLUNTARY LICENSING AND DELAYS IN DRUG REGISTRATION BY ORIGINATOR COMPANIES. THE HCV PROJECT ADVOCATES FOR HARM REDUCTION AND DRUG DECRIMINALIZATION EFFORTS, INCLUDING SUPPORT FOR OVERDOSE PREVENTION AND SAFE CONSUMPTION SITES, AS INJECTION DRUG USE WITHOUT ACCESS TO SAFE MATERIALS IS A MAJOR FACTOR IN HCV TRANSMISSION.IN THE U.S., TAG'S POLICY TEAM WORKS AT THE LOCAL, STATE, AND NATIONAL LEVELS: ADVOCATING FOR VIRAL HEPATITIS FUNDING, CHAMPIONING COVERAGE FOR PEOPLE WHO USE DRUGS, INCARCERATED OR OTHERWISE MARGINALIZED PEOPLE, ENCOURAGING VOLUME-BASED PRICING DEALS FOR DAAS, STRENGTHENING NATIONAL SURVEILLANCE AND SUPPORTING COMMUNITY ENGAGEMENT. TAG'S ADVOCACY HELPED ADVANCE COVERAGE FOR UNIVERSAL ADULT HCV SCREENING AND DRIVE NEW YORK STATE'S COMMITMENT TO ELIMINATE HCV-THE FIRST IN THE NATION!-WITH TAG PARTICIPATING IN THE RESULTANT STATEWIDE HCV ELIMINATION TASK FORCE.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0307575
IRS990/ProgSrvcAccomActy3Grp/Desc0SEE SCHEDULE OTBTHOUGH PREVENTABLE AND CURABLE, TUBERCULOSIS (TB) IS THE LEADING CAUSE OF DEATH OF PEOPLE WITH HIV, AND THE LEADING INFECTIOUS KILLER GLOBALLY. RECOGNIZING THAT MUCH MORE PROGRESS COULD BE MADE IF EXISTING TOOLS WERE FULLY IMPLEMENTED, AND THAT MORE RESEARCH IS NEEDED TO END TB, TAG'S TB PROJECT STRENGTHENS EVIDENCE-DRIVEN AND HUMAN RIGHTS-BASED ADVOCACY BOTH FOR BETTER TB RESEARCH, AND FOR HIGH-QUALITY PROGRAMS AND POLICIES WORLDWIDE, THAT MEET THE NEEDS OF AFFECTED COMMUNITIES.TAG'S TB PROJECT EDUCATES, MOBILIZES, AND EMPOWERS COMMUNITIES TO INCREASE COMMUNITY UNDERSTANDING OF TB AND TO CATALYZE ACTION TO REDUCE NEW INFECTIONS, DEATHS, AND SUFFERING FROM TB AND TB/HIV. THE PROJECT WORKS WITH COMMUNITY ADVOCATES (INCLUDING COMMUNITY ADVISORY BOARDS), RESEARCHERS, POLICY MAKERS, DEVELOPERS, AND DONORS TO ENSURE NEEDS-DRIVEN RESEARCH TO IMPROVE OPTIONS FOR TB PREVENTION, DIAGNOSIS, AND TREATMENT. THE TB PROJECT PUBLISHES AN ANNUAL REPORT ON TB RESEARCH FUNDING TRENDS, AND ADVOCATES FOR ALL GOVERNMENTS OF THE WORLD TO STEP UP AND CONTRIBUTE THEIR "FAIR SHARE" INVESTMENTS IN TB R&D.THE TB PROJECT WORKS AROUND THE WORLD TO ENSURE TRANSPARENCY AND BROAD, EQUITABLE, AFFORDABLE ACCESS TO PROVEN INTERVENTIONS, FROM EARLY IN THE RESEARCH PROCESS THROUGH REGULATORY APPROVAL TO GLOBAL AND NATIONAL GUIDELINES DEVELOPMENT AND PRODUCT PRICING. TAG'S POLICY TEAM SUPPORTS THE TB PROJECT IN EDUCATING U.S. LEGISLATORS ON TB PRIORITIES, AND LEADS DOMESTIC WORK AT THE LOCAL, STATE, AND NATIONAL LEVEL TO SUPPORT AMBITIOUS AND EVIDENCE-BASED PROGRAMMING TO END TB.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt01246647
IRS990/ProgSrvcAccomActy3Grp/GrantAmt047535
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01781719
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt044059
IRS990/PYInvestmentIncomeAmt01668
IRS990/PYOtherExpensesAmt0946408
IRS990/PYOtherRevenueAmt09882
IRS990/PYProgramServiceRevenueAmt015945
IRS990/PYRevenuesLessExpensesAmt0-701749
IRS990/PYSalariesCompEmpBnftPaidAmt01520496
IRS990/PYTotalExpensesAmt02510963
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01809214
IRS990/QuidProQuoContributionsInd01
IRS990/QuidProQuoContriDisclInd01
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-590354
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd01
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt027413

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.84$0.75$3.09$3.57$4.09$0.52
2023Detailed filing. Detailed filing data is available for this year.$4.62$1.01$3.61$4.74$3.74$0.99
2022Detailed filing. Detailed filing data is available for this year.$3.55$0.93$2.62$2.91$3.71$0.80
2021Detailed filing. Detailed filing data is available for this year.$3.78$0.36$3.42$2.71$3.66$0.95
2020Detailed filing. Detailed filing data is available for this year.$4.65$0.28$4.37$4.69$2.99$1.70
2019Detailed filing. Detailed filing data is available for this year.$2.74$0.07$2.66$2.17$2.76$0.59
2018Detailed filing. Detailed filing data is available for this year.$3.32$0.07$3.25$1.81$2.51$0.70
2017Detailed filing. Detailed filing data is available for this year.$2.58$0.08$2.50$2.62$2.64$0.02
2016Detailed filing. Detailed filing data is available for this year.$2.59$0.07$2.52$1.62$2.69$1.07
2015Detailed filing. Detailed filing data is available for this year.$3.61$0.02$3.59$2.23$2.42$0.19
2014Detailed filing. Detailed filing data is available for this year.$3.81$0.03$3.78$4.42$2.48$1.94
2013Detailed filing. Detailed filing data is available for this year.$1.88$0.04$1.84$1.46$2.44$0.98
2012Summary only. Only limited summary data is available for this year.$2.85$0.03$2.83$2.04$1.87$0.17
2011Summary only. Only limited summary data is available for this year.$2.68$0.02$2.66$1.89$1.68$0.21
2010Summary only. Only limited summary data is available for this year.$2.25$0.00$2.25$1.91$2.20$0.29